您的位置: 首页 > 农业专利 > 详情页

Methods for treating atopic dermatitis by administering an IL-4R antagonist
专利权人:
Regeneron Pharmaceuticals, Inc.; Inc.;Sanofi Biotechnology;Regeneron Pharmaceuticals
发明人:
Ardeleanu, Marius,Graham, Neil,Hamilton, Jennifer D.,Kirkesseli, Stephane C.,Kundu, Sudeep,Ming, Jeffrey,Radin, Allen,Rocklin, Ross E.,Weinstein, Steven P.
申请号:
AU2013312868
公开号:
AU2013312868B2
申请日:
2013.09.04
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
The present invention provides methods for treating atopic dermatitis (AD). Also provided are methods for improving one or more AD-associated parameter(s), and methods for decreasing the level of at least one AD-associated biomarker in a subject in need thereof. The methods of the present invention comprise administering to a subject in need thereof a pharmaceutical composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充